Tinzaparin

The Basics

What is Tinzaparin?

Used for once daily treatment and prophylaxis of deep vein thrombosis and pulmonary embolism.

Brand names for Tinzaparin

Innohep

How Tinzaparin is classified

Anticoagulants, Low Molecular Weight Heparin

Tinzaparin During Pregnancy

Tinzaparin pregnancy category

Category BNote that the FDA has deprecated the use of pregnancy categories, so for some medications, this information isn’t available. We still think it’s useful to list historical info, however, given what a common proxy this has been in the past.

What we know about taking Tinzaparin while pregnant

All pregnancies have a background risk of birth defects, loss, or other adverse outcome regardless of drug exposure. The fetal risk summary below describes the potential of INNOHEP® (tinzaparin) to increase the risk of developmental abnormalities above background risk.

Taking Tinzaparin While Breastfeeding

What are recommendations for lactation if you're taking Tinzaparin?

Although tinzaparin has not been studied, other low molecular weight heparins (e.g., dalteparin, enoxaparin) are not excreted into breastmilk in clinically relevant amounts. Because there is no published experience with tinzaparin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Maternal / infant drug levels

Although tinzaparin has not been studied, other low molecular weight heparins (e.g., dalteparin, enoxaparin) are not excreted into breastmilk in clinically relevant amounts. Because there is no published experience with tinzaparin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Possible effects of Tinzaparin on milk supply

Relevant published information was not found as of the revision date.

Possible alternatives to Tinzaparin